CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
7 stories
🇧🇷 G1 (PT)
National & Local

UFSCar offers rehabilitation for those with chronic obstructive pulmonary disease

The Federal University of São Carlos (UFSCar) is developing a rehabilitation program for patients with chronic obstructive pulmonary disease (COPD) in São Carlos, Brazil.

Feb 28 • 14:16 UTC
🇧🇷 Folha (PT)
National & Local

Obesity and inflammation may accelerate lung aging, points out Brazilian study

A Brazilian study of nearly 900 participants under 40 found that early lung aging is linked not just to smoking, but also to obesity and systemic inflammation.

Feb 20 • 19:00 UTC
🇯🇵 Asahi Shimbun (JP)
National & Local

Understanding the Causes of Pulmonary Fibrosis Using Human iPS Cells, and Identifying Candidate Drugs - Kyoto University

A research team from Kyoto University has used human iPS cells to elucidate the causes of idiopathic pulmonary fibrosis and identify potential drug candidates for treatment.

Feb 12 • 10:00 UTC
🇬🇷 Naftemporiki
National & Local

COPD a significant risk factor for lung cancer – Awareness campaign for Lung Care

AstraZeneca launches an initiative aimed at promoting lung health, focusing on the connection between Chronic Obstructive Pulmonary Disease (COPD) and lung cancer.

Feb 11 • 16:47 UTC
🇫🇮 Ilta-Sanomat
National & Local

If this common disease strikes, there is an urgent need for treatment - mortality increases when diagnosis is delayed

A study reveals that delayed diagnosis of venous thrombosis or pulmonary embolism significantly increases the risk of mortality for patients.

Feb 8 • 04:15 UTC
🇬🇧 Mirror
National & Local

Chuck Negron dead: Three Dog Night singer passes away after long career

Chuck Negron, the founding member of the rock band Three Dog Night, has passed away at the age of 83 at his home in Los Angeles due to heart failure and chronic obstructive pulmonary disease.

Feb 3 • 05:02 UTC
🇮🇹 Il Giornale
National & Local

Pulmonary arterial hypertension, an innovative drug is coming to Italy

A new drug, sotatercept, has been approved for reimbursement in Italy for adult patients with pulmonary arterial hypertension, marking a significant advancement in treatment options for this rare disease.

Feb 2 • 15:32 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.